Psychiatry drugs

51 drugs with cited findings from FDA review packages and EMA assessment reports. Every figure on every page cites its source document and page.

By condition

Schizophrenia (20)Major depressive disorder (9)ADHD (9)Bipolar disorder (6)Agitation in Alzheimer's dementia (2)Insomnia (3)Opioid use disorder (6)

By drug class

Antipsychotics (4)Orexin receptor antagonists (2)Buprenorphine-based therapies (4)Long-acting injectable antipsychotics (2)

Endpoints & rating scales explained

PANSS (Positive and Negative Syndrome Scale)MADRS (Montgomery-Asberg Depression Rating Scale)CGI (Clinical Global Impression)HAM-D (Hamilton Depression Rating Scale)Objective sleep endpoints (WASO, LPS, TST)ADHD-RS (ADHD Rating Scale)C-SSRS (Columbia Suicide Severity Rating Scale)YMRS (Young Mania Rating Scale)

Spravato

Johnson & Johnson · 2897 cited findings

Rxulti

Otsuka Holdings Co., Ltd. · 2326 cited findings

Zurzuvae

Biogen Inc. · 2135 cited findings

Cobenfy

Bristol-Myers Squibb Company · 2011 cited findings

Rexulti

Otsuka Holdings Co., Ltd. · 1889 cited findings

Qelbree / viloxazine ER

Supernus Pharmaceuticals, Inc. · 1562 cited findings

DAYVIGO

Eisai Co., Ltd. · 1548 cited findings

Caplyta

Johnson & Johnson · 1442 cited findings

Latuda

Angelini Pharma · 1442 cited findings

Quviviq

Idorsia Ltd · 1352 cited findings

Vraylar

AbbVie Inc. · 1331 cited findings

CAM2038

Braeburn · 989 cited findings

Brintellix

H. Lundbeck A/S · 986 cited findings

Sunosi

Pharmanovia · 927 cited findings

Auvelity

Axsome Therapeutics, Inc. · 925 cited findings

Reagila

Gedeon Richter Plc. · 910 cited findings

Uzedy

Teva Pharmaceutical Industries Limited · 904 cited findings

Azstarys

COMMAVE SUB · 748 cited findings

Nuplazid

ACADIA Pharmaceuticals Inc. · 732 cited findings

Lybalvi

Alkermes plc · 669 cited findings

Xelstrym

NOVEN PHARMS INC · 609 cited findings

Lucemyra

BIOCORRX PHARMS · 597 cited findings

Slenyto

RAD Neurim Pharmaceuticals · 580 cited findings

Exxua

FABRE KRAMER · 571 cited findings

Hetlioz

Vanda Pharmaceuticals Inc. · 445 cited findings

Rykindo

SHANDONG LUYE · 444 cited findings

Xeplion

Johnson & Johnson · 433 cited findings

Sycrest

Organon & Co. · 421 cited findings

Buvidal

Camurus · 407 cited findings

Secuado (asenapine) transdermal system

HISAMITSU · 387 cited findings

Jornay Pm

Ironshore Pharmaceuticals · 377 cited findings

Trevicta

Johnson & Johnson · 368 cited findings

Trintellix

Takeda Pharmaceutical Company Limited · 350 cited findings

Aristada Initio

Alkermes plc · 344 cited findings

Erzofri

LUYE INNOMIND PHARMA · 325 cited findings

Okedi

Laboratorios Farmaceuticos Rovi, S.A. · 271 cited findings

COTEMPLA XR-ODT

NEOS THERAPS INC · 255 cited findings

Trintellix (vortioxetine) Tablets

Takeda Pharmaceutical Company Limited · 247 cited findings

Byannli

Unknown MAH · 228 cited findings

Sublocade

Indivior PLC · 226 cited findings

Abilify Asimtufii (aripiprazole) injection

Otsuka Holdings Co., Ltd. · 216 cited findings

Brixadi

Braeburn · 211 cited findings

ADASUVE

Ferrer Internacional · 210 cited findings

Selincro

H. Lundbeck A/S · 202 cited findings

Brexpiprazole

Otsuka Holdings Co., Ltd. · 202 cited findings

Abilify Maintena

Otsuka Holdings Co., Ltd. · 202 cited findings

Dyanavel XR

Tris Pharma · 175 cited findings

Tuzulby

Neuraxpharm · 172 cited findings

Onyda XR

Tris Pharma · 80 cited findings

Ingrezza Sprinkle

Neurocrine Biosciences, Inc. · 69 cited findings

Zubsolv

Accord S L U · 63 cited findings

Educational reference only — not medical or investment advice.